Insights on multiple myeloma treatment strategies

Mateos, M.V. (María Victoria); Ludwig, H. (Heinz); Bazarbachi, A. (Ali); Beksac, M. (Meral); Bladé, J. (Joan); Boccadoro, M. (Mario); Cavo, M. (Michele); Delforge, M. (M.); Dimopoulos, M.A. (Meletios A.); Facon, T. (Thierry); Geraldes, C. (Catarina); Goldschmidt, H. (Hartmut); Hajek, R. (R.); Hansson, M. (Markus); Jamroziak, K. (Krzysztof); Leiba, M. (Merav); Masszi, T. (Tamás); Mendeleeva, L. (Larisa); O’Dwyer, M. (Michael); Plesner, T. (Torben); San-Miguel, J.F. (Jesús F.); Straka, C. (Christian); Donk, N.W.C.J. (Niels W.C.J.) van de; Yong, K. (Kwee); Zver, S. (Samo); Moreau, P. (Philippe); Sonneveld, P. (Pieter)

Full metadata record

Appears in Collections:

DA - CIMA - Hemato-oncología - Mieloma - Artículos de Revista
DA - CUN - Hematología y Hemoterapia - Artículos de revista

DC Field	Value	Language
dc.creator	Mateos, M.V. (María Victoria)	-
dc.creator	Ludwig, H. (Heinz)	-
dc.creator	Bazarbachi, A. (Ali)	-
dc.creator	Beksac, M. (Meral)	-
dc.creator	Bladé, J. (Joan)	-
dc.creator	Boccadoro, M. (Mario)	-
dc.creator	Cavo, M. (Michele)	-
dc.creator	Delforge, M. (M.)	-
dc.creator	Dimopoulos, M.A. (Meletios A.)	-
dc.creator	Facon, T. (Thierry)	-
dc.creator	Geraldes, C. (Catarina)	-
dc.creator	Goldschmidt, H. (Hartmut)	-
dc.creator	Hajek, R. (R.)	-
dc.creator	Hansson, M. (Markus)	-
dc.creator	Jamroziak, K. (Krzysztof)	-
dc.creator	Leiba, M. (Merav)	-
dc.creator	Masszi, T. (Tamás)	-
dc.creator	Mendeleeva, L. (Larisa)	-
dc.creator	O’Dwyer, M. (Michael)	-
dc.creator	Plesner, T. (Torben)	-
dc.creator	San-Miguel, J.F. (Jesús F.)	-
dc.creator	Straka, C. (Christian)	-
dc.creator	Donk, N.W.C.J. (Niels W.C.J.) van de	-
dc.creator	Yong, K. (Kwee)	-
dc.creator	Zver, S. (Samo)	-
dc.creator	Moreau, P. (Philippe)	-
dc.creator	Sonneveld, P. (Pieter)	-
dc.date.accessioned	2021-10-25T10:18:23Z	-
dc.date.available	2021-10-25T10:18:23Z	-
dc.date.issued	2018	-
dc.identifier.citation	Mateos, M.V. (María Victoria); Ludwig, H. (Heinz); Bazarbachi, A. (Ali); et al. "Insights on multiple myeloma treatment strategies". HemaSphere. 3 (1), 2018, e163	es_ES
dc.identifier.issn	2572-9241	-
dc.identifier.uri	https://hdl.handle.net/10171/62270	-
dc.description.abstract	The introduction of new agents and management strategies over the past decade has resulted in a major step change in treatment outcomes with deepening responses and increased survival for patients with multiple myeloma. In daily clinical practice, healthcare professionals are now faced with challenges including, optimal treatment sequencing and changing treatment goals. In light of this, a group of experts met to discuss diagnostic and treatment guidelines, examine current clinical practice, and consider how new clinical trial data may be integrated into the management of multiple myeloma in the future.	es_ES
dc.description.sponsorship	The consensus meeting was supported by Janssen Pharmaceutica NV. Editorial support for the manuscript was funded by the European Myeloma Network	es_ES
dc.language.iso	eng	es_ES
dc.publisher	Ovid Technologies (Wolters Kluwer Health)	es_ES
dc.rights	info:eu-repo/semantics/openAccess	es_ES
dc.subject	Myeloma	es_ES
dc.subject	Treatment Strategies	es_ES
dc.subject	Therapies	es_ES
dc.subject	Biomarkers	es_ES
dc.subject	Delay progression	es_ES
dc.title	Insights on multiple myeloma treatment strategies	es_ES
dc.type	info:eu-repo/semantics/article	es_ES
dc.description.note	This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.	es_ES
dc.identifier.doi	10.1097/HS9.0000000000000163	-
dadun.citation.number	1	es_ES
dadun.citation.publicationName	HemaSphere	es_ES
dadun.citation.startingPage	e163	es_ES
dadun.citation.volume	3	es_ES